Author: Bharat, A.; Querrey, M.; Markov, N. S.; Kim, S. S.; Kurihara, C.; Garza-Castillon, R.; Manerikar, A.; Shilatifard, A.; Tomic, R.; Politanska, Y.; Abdala-Valencia, H.; Yeldandi, A. V.; Lomasney, J. W.; Misharin, A. V.; Budinger, G. S.
Title: Lung transplantation for pulmonary fibrosis secondary to severe COVID-19 Cord-id: yl61aq0a Document date: 2020_10_27
ID: yl61aq0a
Snippet: Lung transplantation can potentially be a life-saving treatment for patients with non-resolving COVID-19 acute respiratory distress syndrome. Concerns limiting transplant include recurrence of SARS-CoV-2 infection in the allograft, technical challenges imposed by viral-mediated injury to the native lung, and potential risk for allograft infection by pathogens associated with ventilator-induced pneumonia in the native lung. Additionally, the native lung might recover, resulting in long-term outco
Document: Lung transplantation can potentially be a life-saving treatment for patients with non-resolving COVID-19 acute respiratory distress syndrome. Concerns limiting transplant include recurrence of SARS-CoV-2 infection in the allograft, technical challenges imposed by viral-mediated injury to the native lung, and potential risk for allograft infection by pathogens associated with ventilator-induced pneumonia in the native lung. Additionally, the native lung might recover, resulting in long-term outcomes preferable to transplant. Here, we report the results of the first two successful lung transplantation procedures in patients with non-resolving COVID-19 associated acute respiratory distress syndrome in the United States. We performed smFISH to detect both positive and negative strands of SARS-CoV-2 RNA in the explanted lung tissue, extracellular matrix imaging using SHIELD tissue clearance, and single cell RNA-Seq on explant and warm post-mortem lung biopsies from patients who died from severe COVID-19 pneumonia. Lungs from patients with prolonged COVID-19 were free of virus but pathology showed extensive evidence of injury and fibrosis which resembled end-stage pulmonary fibrosis. Single cell RNA-Seq of the explanted native lungs from transplant and paired warm post-mortem autopsies showed similarities between late SARS-CoV-2 acute respiratory distress syndrome and irreversible end-stage pulmonary fibrosis requiring lung transplantation. There was no recurrence of SARS-CoV-2 or pathogens associated with pre-transplant ventilator-associated pneumonias following transplantation in either patient. Our findings suggest that some patients with severe COVID-19 develop fibrotic lung disease for which lung transplantation is the only option for survival.
Search related documents:
Co phrase search for related documents- active case and acute respiratory: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- active case and acute respiratory distress syndrome: 1, 2, 3, 4
- acute respiratory and additional sample: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- acute respiratory and adequate oxygenation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute respiratory and adequate oxygenation maintain: 1, 2, 3, 4, 5, 6
- acute respiratory and liver capsular: 1
- acute respiratory and liver capsular bleed: 1
- acute respiratory distress syndrome and additional sample: 1
- acute respiratory distress syndrome and adequate oxygenation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
- acute respiratory distress syndrome and adequate oxygenation maintain: 1, 2
- acute respiratory distress syndrome and liver capsular: 1
- acute respiratory distress syndrome and liver capsular bleed: 1
Co phrase search for related documents, hyperlinks ordered by date